Skip to main content

A twisted tale of PRES

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2


  1. Wang X (1999) A theory for the mechanism of homocysteine-induced vascular pathogenesis. Med Hypotheses 53(5):386–394

    Article  CAS  PubMed  Google Scholar 

  2. Bhojwani D1, Sabin ND, Pei D, Yang JJ, Khan RB, Panetta JC, Krull KR, Inaba H, Rubnitz JE, Metzger ML, Howard SC, Ribeiro RC, Cheng C, Reddick WE, Jeha S, Sandlund JT, Evans WE, Pui CH, Relling MV (2014) Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. J Clin Oncol 32(9):949–959. doi:10.1200/JCO.2013.53.0808

  3. Patel A1, Ayto R, MacDonald DH (2013) Posterior reversible encephalopathy after intrathecalmethotrexate therapy in diffuse large B-cell lymphoma. Br J Haematol 161(5):607. doi: 10.1111/bjh.12331

  4. Weigel R1, Senn P, Weis J, Krauss JK (2004) Severe complications after intrathecalmethotrexate (MTX) for treatment of primary central nervous system lymphoma (PCNSL), Clin Neurol Neurosurg 106(2):82–87

  5. Renard D, Westhovens R, Vandenbussche E, Vandenberghe R (2004) Reversible posterior leucoencephalopathy during oral treatment with methotrexate. J Neurol 251(2):226–228

    Article  PubMed  Google Scholar 

Download references

Conflict of interest


Author information

Authors and Affiliations


Corresponding author

Correspondence to Kaustubh Limaye.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Limaye, K., Patel, A., Bianchi, N. et al. A twisted tale of PRES. Acta Neurol Belg 115, 187–189 (2015).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


  • Homocysteine
  • Posterior Reversible Encephalopathy Syndrome
  • Vasogenic Edema
  • C677T MTHFR
  • Oral Methotrexate